COMMUNIQUÉS West-GlobeNewswire

Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders
29/03/2019
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders Amsterdam, The Netherlands, March 29, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]
Genfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
29/03/2019
FOR IMMEDIATE RELEASE GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares Global Offering Gross Proceeds Totaling $155.4 Million Lille [...]
Genfit : GENFIT annonce le règlement-livraison de l’Offre Globale
29/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Vigil Health Solutions Establishes Automatic Share Purchase Plan
29/03/2019
VICTORIA, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“ V i g i l ” or the “ Company ”) (TSX-VEN: VGL) today announced that, in connection with its previously announced normal [...]
Increase in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
29/03/2019
The number of shares and votes in Oasmia Pharmaceutical AB (publ) has increased as a result of the directed new share issue carried out in March 2019. Through the directed share issue the number of outstanding shares [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019
29/03/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Ossur Hf : Registration of capital reduction of 5,430,259 shares completed
29/03/2019
Announcement no. 21/2019 29 March 2019 Registration of capital reduction of 5,430,259 shares completed Reference is made to the Company's announcement no. 16/2019 published on 7 March 2019. The capital reduction of ISK [...]
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
29/03/2019
PORTLAND, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Cytovance Biologics Congratulates Siwa Biotech on Commercial Medical Device Approval
29/03/2019
OKLAHOMA CITY, March 29, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics announces Siwa Biotech’s receipt of FDA licensure of Anti-Fy a and Anti-Fy b recombinant monoclonal Blood Grouping Reagents. These reagents were [...]
Summary of capital reduction pursuant to Article 32 of the Danish Capital
29/03/2019
Please read the full announcement here Attachment 2019_05_Summary_of_capital_reduction_EN
Theratechnologies Appoints New Board Member
29/03/2019
MONTREAL, March 29, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced the appointment of Ms. Sheila M. Frame as a new independent member to its Board of Directors. “Sheila is [...]
Theratechnologies nomme un nouveau membre à son conseil d’administration
29/03/2019
MONTRÉAL, 29 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de Mme Sheila M. Frame à titre d’administratrice indépendante du conseil d’administration de la [...]
Reduction of common stock
29/03/2019
Please read the full announcement here Attachment 2019_04_Reduction_of_common_stock_EN
OpGen Announces Closing of Public Offering of Common Stock
29/03/2019
GAITHERSBURG, Md., March 29, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today the closing of its previously announced underwritten public offering of 9 million shares of its common stock at a public [...]
Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study
29/03/2019
Hamilton, Bermuda, March 29, 2019 - Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Wildflower Featured in CannabisNewsAudio Publication on CBD Entering Mainstream Acceptance
29/03/2019
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Publication titled, “ CBD Going Mainstream amid Flood [...]
Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update
29/03/2019
LOS ANGELES, March 29, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat [...]
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
29/03/2019
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “ Advanced Medical Technologies Provides Unprecedented [...]
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
29/03/2019
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL, March 29, 2019 (GLOBE [...]

Pages